Global Drugs for Sinusitis Market 2016 by Sanofi, Bayer AG, AstraZeneca Plc, Merck, Amgen to 2021
Sinusitis, also known as a sinus infection or rhinosinusitis, is inflammation of the sinuses resulting in symptoms. Common signs and symptoms include thick nasal mucus, a plugged nose, and pain in the face. Other signs and symptoms may include fever, headaches, poor sense of smell, sore throat, and cough. The cough is often worse at night. Serious complications are rare. It is defined as acute rhinosinusitis (ARS) if it lasts less than 4 weeks, and chronic rhinosinusitis (CRS) if it lasts for more than 12 weeks.
Scope of the Report:
This report focuses on the Drugs for Sinusitis in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers
Johnson & Johnson
Dr. Reddy’s Laboratories
Request For Sample Report: http://www.fiormarkets.com/report-detail/14455/request-sample
Market Segment by Regions
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa
Market Segment by Type
Market Segment by Applications
There are 13 Chapters to deeply display the global Drugs for Sinusitis market report.